SCHEMBL236627

SCHEMBL236627

COc1ccccc1-c1coc2c(C)c(O)ccc2c1=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.60
KDM4E B2RXH2 5/20 0.60
HPGD P15428 5/20 0.60
HSD17B10 Q99714 4/20 0.60
RCE1 Q9Y256 2/20 0.60
CYP3A4 P08684 3/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
POLB P06746 2/20 0.60
USP2 O75604 1/20 0.60
GLA P06280 1/20 0.60
PKM P14618 1/20 0.55
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
ALOX15 P16050 3/20 0.52
HTT P42858 1/20 0.52
RAB9A P51151 1/20 0.52
LMNA P02545 1/20 0.49
TP53 P04637 1/20 0.49
MAPT P10636 1/20 0.49
THRB P10828 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL234836 0.88 ALOX15 (0.64) ALDH1A1KDM4EHPGDHSD17B10RCE1
SCHEMBL232035 0.85 PKM (0.60) ALDH1A1KDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL18222914 0.84 HSD17B10 (0.69) ALDH1A1KDM4EHPGDHSD17B10RCE1
SCHEMBL30903615 0.84 HSD17B10 (0.69) ALDH1A1KDM4EHPGDHSD17B10RCE1
SCHEMBL18222890 0.83 KDM4E (0.67) ALDH1A1KDM4EHPGDHSD17B10RCE1
SCHEMBL30903612 0.83 KDM4E (0.67) ALDH1A1KDM4EHPGDHSD17B10RCE1
SCHEMBL2069772 0.82 MAPT (0.56) ALDH1A1KDM4EHSD17B10CYP3A4SMN1; SMN2
SCHEMBL330358 0.81 MAPT (0.63) ALDH1A1KDM4EHSD17B10CYP3A4SMN1; SMN2
SCHEMBL30903592 0.81 KDM4E (0.74) ALDH1A1KDM4EHPGDHSD17B10RCE1
SCHEMBL12325242 0.81 KDM4E (0.74) ALDH1A1KDM4EHPGDHSD17B10RCE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346844-B1 SUBSTITUTED BENZFUROCHROMENES FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS COUNCIL SCIENT IND RES (IN) 2017-09-20 EP disclosed
US-20120003273-A1 SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGISTRATION OF SOCIETIES ACT (ACT XXI OF 1860)) (IN) 2012-01-05 US disclosed
EP-2346844-A1 SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS Council Of Scientific & Industrial Research (IN) 2011-07-27 EP disclosed
WO-2010052734-A1 SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2010-05-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120003273-A1 SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS AKR1C3, AKR1C4, SLC10A1 ALDH1A1 1999/4885KDM4E 2194/4885HPGD 1138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.